Authors
Latest Article
Gloomy Number Forecast
Robert Giugliano, MD, is a senior investigator with the TIMI Study Group, staff physician in the Cardiovascular Division at Brigham and Women’s Hospital, and associate professor of medicine at Harvard Medical School. Dr. Giugliano’s areas of research interest include novel antithrombotic, fibrinolytic agents, and lipid-lowering therapies, and patient outcomes following Acute Coronary Syndromes. He has authored more than 200 articles and chapters, and delivered hundreds of lectures. Dr. Giugliano is the principal investigator for the ENGAGE-AF TIMI 48 trial, and a member of the Operations Committees and lead TIMI investigator for the IMPROVE-IT, FOURIER, and EARLY ACS trials.
Advertisement
Advertisement
Trending on HCPLive
1
Chronic Hypoparathyroidism Today: Unmet Needs, Conventional Therapy Limits, and the Shift to PTH Replacement
2
SIGNAL-AA: Bempikibart Effective for Alopecia Areata at 36 Weeks
3
AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines
4
Avapritinib 4-Year PIONEER Data: Sustained QoL Gains in ISM
5

